Novelix Pharmaceuticals Statistics
Total Valuation
BOM:536565 has a market cap or net worth of INR 1.96 billion. The enterprise value is 2.00 billion.
| Market Cap | 1.96B |
| Enterprise Value | 2.00B |
Important Dates
The last earnings date was Wednesday, November 11, 2026.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:536565 has 28.47 million shares outstanding. The number of shares has increased by 124.52% in one year.
| Current Share Class | 28.47M |
| Shares Outstanding | 28.47M |
| Shares Change (YoY) | +124.52% |
| Shares Change (QoQ) | +13.99% |
| Owned by Insiders (%) | 34.84% |
| Owned by Institutions (%) | 0.88% |
| Float | 7.78M |
Valuation Ratios
The trailing PE ratio is 42.24.
| PE Ratio | 42.24 |
| Forward PE | n/a |
| PS Ratio | 1.28 |
| PB Ratio | 3.05 |
| P/TBV Ratio | 3.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 43.52 |
| EV / Sales | 1.31 |
| EV / EBITDA | 33.57 |
| EV / EBIT | 35.15 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.10.
| Current Ratio | 1.90 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 1.08 |
| Debt / FCF | n/a |
| Interest Coverage | 21.50 |
Financial Efficiency
Return on equity (ROE) is 10.24% and return on invested capital (ROIC) is 8.39%.
| Return on Equity (ROE) | 10.24% |
| Return on Assets (ROA) | 3.35% |
| Return on Invested Capital (ROIC) | 8.39% |
| Return on Capital Employed (ROCE) | 8.03% |
| Weighted Average Cost of Capital (WACC) | 5.39% |
| Revenue Per Employee | 48.51M |
| Profits Per Employee | 1.46M |
| Employee Count | 32 |
| Asset Turnover | 1.44 |
| Inventory Turnover | 16.03 |
Taxes
In the past 12 months, BOM:536565 has paid 8.39 million in taxes.
| Income Tax | 8.39M |
| Effective Tax Rate | 15.26% |
Stock Price Statistics
The stock price has increased by +25.02% in the last 52 weeks. The beta is 0.22, so BOM:536565's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | +25.02% |
| 50-Day Moving Average | 69.57 |
| 200-Day Moving Average | 65.53 |
| Relative Strength Index (RSI) | 55.38 |
| Average Volume (20 Days) | 4,148 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:536565 had revenue of INR 1.55 billion and earned 46.58 million in profits. Earnings per share was 1.66.
| Revenue | 1.55B |
| Gross Profit | 83.12M |
| Operating Income | 57.69M |
| Pretax Income | 54.97M |
| Net Income | 46.58M |
| EBITDA | 60.40M |
| EBIT | 57.69M |
| Earnings Per Share (EPS) | 1.66 |
Balance Sheet
The company has 32.15 million in cash and 65.26 million in debt, with a net cash position of -33.12 million or -1.16 per share.
| Cash & Cash Equivalents | 32.15M |
| Total Debt | 65.26M |
| Net Cash | -33.12M |
| Net Cash Per Share | -1.16 |
| Equity (Book Value) | 653.48M |
| Book Value Per Share | 23.83 |
| Working Capital | 642.06M |
Cash Flow
In the last 12 months, operating cash flow was -303.30 million and capital expenditures -58.47 million, giving a free cash flow of -361.77 million.
| Operating Cash Flow | -303.30M |
| Capital Expenditures | -58.47M |
| Depreciation & Amortization | 2.71M |
| Net Borrowing | 7.73M |
| Free Cash Flow | -361.77M |
| FCF Per Share | -12.71 |
Margins
Gross margin is 5.35%, with operating and profit margins of 3.72% and 3.00%.
| Gross Margin | 5.35% |
| Operating Margin | 3.72% |
| Pretax Margin | 3.54% |
| Profit Margin | 3.00% |
| EBITDA Margin | 3.89% |
| EBIT Margin | 3.72% |
| FCF Margin | n/a |
Dividends & Yields
BOM:536565 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -124.52% |
| Shareholder Yield | -124.52% |
| Earnings Yield | 2.37% |
| FCF Yield | -18.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on October 4, 2010. It was a reverse split with a ratio of 0.1.
| Last Split Date | Oct 4, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |